GlaxoSmithKline Pharmaceuticals Ltd.

BSE: 500660 | NSE: GLAXO |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE159A01016 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

GlaxoSmithKlin GlaxoSmithKline Pharmaceuticals Ltd. | BSE 2311.50 -68.35 (-2.87%) | NSE 2313.40 -66.80 (-2.81%) | Trade | Add

BSE Live

Jan 23, 16:01

2311.50 -68.35 (-2.87%)

Volume

AVERAGE VOLUME

5-Day

3,461

10-Day

2,957

30-Day

5,758

3,136

Prev. Close

2379.85
Open Price

2390.85

Bid Price (Qty.)
2308.05 (1)
Offer Price (Qty.)
2400.00 (21)

NSE Live

Jan 23, 15:58

2313.40 -66.80 (-2.81%)

Volume

AVERAGE VOLUME

5-Day

79,911

10-Day

69,951

30-Day

83,035

86,873

Prev. Close

2380.20
Open Price

2381.90

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2313.40 (10)

Financials

Print/Copy to Excel : Go

Key Financial Ratios of GlaxoSmithKline Pharmaceuticals (in Rs. Cr.)	Dec 09	Dec 08	Dec 07	Dec 06	Dec 05
Per Share Ratios
Basic EPS (Rs.)	60.48	68.07	63.48	64.40	59.28
Diluted EPS (Rs.)	60.48	68.07	63.48	64.40	59.28
Cash EPS (Rs.)	62.41	70.00	65.38	66.27	61.13
Book Value [ExclRevalReserve]/Share (Rs.)	207.68	181.94	160.67	141.05	111.99
Book Value [InclRevalReserve]/Share (Rs.)	207.68	181.94	160.67	141.05	111.99
Dividend / Share(Rs.)	30.00	40.00	36.00	31.00	28.00
Revenue from Operations/Share (Rs.)	222.44	197.91	186.37	182.04	174.03
PBDIT/Share (Rs.)	91.20	82.20	73.65	66.79	56.73
PBIT/Share (Rs.)	89.27	80.27	71.75	64.92	54.87
PBT/Share (Rs.)	89.22	80.21	71.67	64.84	54.67
Net Profit/Share (Rs.)	60.48	68.07	63.48	64.40	59.28
Profitability Ratios
PBDIT Margin (%)	40.99	41.53	39.52	36.69	32.59
PBIT Margin (%)	40.13	40.55	38.49	35.66	31.52
PBT Margin (%)	40.11	40.52	38.45	35.62	31.41
Net Profit Margin (%)	27.18	34.39	34.05	35.37	34.06
Return on Networth / Equity (%)	29.12	37.41	39.50	45.66	52.92
Return on Capital Employed (%)	28.90	37.05	39.06	45.05	52.03
Return on Assets (%)	20.72	25.26	26.69	30.70	33.18
Total Debt/Equity (X)	0.00	0.00	0.00	0.00	0.01
Asset Turnover Ratio (%)	76.22	73.46	78.38	86.78	97.42
Liquidity Ratios
Current Ratio (X)	3.02	1.92	0.87	0.90	0.84
Quick Ratio (X)	2.66	1.60	0.55	0.47	0.44
Inventory Turnover Ratio (X)	7.45	7.34	7.66	6.40	6.76
Dividend Payout Ratio (NP) (%)	49.60	58.76	56.71	48.13	47.23
Dividend Payout Ratio (CP) (%)	48.06	57.14	55.05	46.77	45.80
Earnings Retention Ratio (%)	50.40	41.24	43.29	51.87	52.77
Cash Earnings Retention Ratio (%)	51.94	42.86	44.95	53.23	54.20
Valuation Ratios
Enterprise Value (Cr.)	11,970.42	8,814.54	8,574.76	9,833.75	9,446.18
EV/Net Operating Revenue (X)	6.35	5.26	5.43	6.38	6.41
EV/EBITDA (X)	15.50	12.66	13.74	17.38	19.66
MarketCap/Net Operating Revenue (X)	7.24	5.80	5.53	6.40	6.44
Retention Ratios (%)	50.39	41.23	43.28	51.86	52.76
Price/BV (X)	7.75	6.30	6.41	8.26	10.00
Price/Net Operating Revenue	7.24	5.80	5.53	6.40	6.44
Earnings Yield	0.04	0.06	0.06	0.06	0.05